Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10520543 | Transfusion Clinique et Biologique | 2013 | 5 Pages |
Abstract
Since its creation in 1993, hemovigilance has an important place for blood safety. The part concerning donors, as the name suggests, targeted on improvement of donor's safety covers in fact the two points of the transfusion chain with serious adverse events in donor, epidemiologic survey for recipients and post-donation information on the two sides. Organized management and close collaboration between the actors of the transfusion chain are necessary to ensure the effectiveness of the system.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
L. Hauser, A. Beyloune, M. Simonet, P. Bierling,